NCT04354181View on ClinicalTrials.gov

Urine Biomarker for Stone Recurrence

CompletedOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

July 24, 2020

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions

Urolithiasis

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT04354181 - Urine Biomarker for Stone Recurrence | Biotech Hunter | Biotech Hunter